Physician profile
Daniel Sircar
NPI 1487231320
$2,585.34
in general payments reported to CMS, 2019-2025
22 companies · $817 in 2025
The $817 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.15 · 2022: $487 · 2023: $516 · 2024: $740 · 2025: $817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,074.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $729.17 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $668.92 | 2022-2025 | Matrixrib |
| Aroa Biosurgery Incorporated | $143.25 | 2022-2024 | |
| Davol INC. | $136.88 | 2025 | Phasix Mesh |
| Endologix LLC | $131.16 | 2024 | Endocross Device, Torus Stent Graft System |
| Enterra Medical, INC. | $125.55 | 2025 | |
| Penumbra, INC. | $86.38 | 2025 | Indigo System |
| Avita Medical Americas, LLC | $75.89 | 2025 | Cohealyx, Recell, Permeaderm |
| Baxter Healthcare | $72.43 | 2021-2023 | Seprafilm, Floseal |
| Tela Bio, INC. | $64.18 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Haemonetics Corporation | $62.42 | 2023-2025 | Teg5000 Hemostasis Analyzer |
| Kerecis Limited | $54.27 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $40.01 | 2023 | Harmonic, Surgicel Nu-Knit, Vistaseal |
| Medline Industries LP | $35.47 | 2022 | |
| Biocomposites INC | $26.38 | 2023 | Stimulan |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $24.52 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.48 | 2023 | Andexxa |
| Lifenet Health | $20.13 | 2024 | Theragenesis Wound Matrix |
| Solventum Corporation | $18.67 | 2025 | V.A.C. Granufoam, Activ.A.C., Prevena |
| Innovation Technologies INC | $18.14 | 2023 | Irrisept |
| Alexion Pharmaceuticals, INC. | $18.11 | 2022 | |
| Kci USA, INC. | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sircar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.